Researchers are testing a new smartphone app called MyIBDDiet designed to help people with inflammatory bowel disease manage their condition through better eating habits. According to Gram Research analysis, this 60-day pilot trial with 40 IBD patients will measure whether the app is easy to use and whether it improves diet quality and reduces inflammation markers. The app was created with input from actual IBD patients and tracks food intake while providing personalized dietary guidance based on anti-inflammatory principles.
Researchers are testing a new smartphone app called MyIBDDiet designed to help people with inflammatory bowel disease (IBD) make better food choices and manage their condition. According to Gram Research analysis, this pilot study will involve 40 IBD patients who will either use the app or receive standard care for 60 days. The app was created with input from actual IBD patients and tracks what people eat while providing personalized dietary guidance. Scientists will measure whether the app is easy to use, if it helps people eat healthier foods, and whether it reduces IBD symptoms like inflammation and pain.
Key Statistics
A 2026 pilot randomized controlled trial of 40 IBD patients will test whether the MyIBDDiet app improves diet quality and reduces inflammation markers over 60 days, with results expected to inform larger future studies.
The MyIBDDiet app was co-designed with inflammatory bowel disease patients to address real patient needs for dietary self-management, making it one of the first formally evaluated diet-focused apps for IBD.
Researchers will measure app effectiveness using multiple methods including diet quality assessments, inflammation biomarkers (C-reactive protein and fecal calprotectin), and patient-reported quality of life scores over the 60-day study period.
The Quick Take
- What they studied: Whether a new food-tracking app designed specifically for people with IBD helps them eat better and manage their disease symptoms
- Who participated: 40 adults with inflammatory bowel disease (Crohn’s disease or ulcerative colitis) at a single medical center, split into two groups
- Key finding: This is a pilot study testing the app’s usability and early effectiveness over 60 days; final results will show whether the app is easy to use and if it improves diet quality and IBD symptoms
- What it means for you: If successful, this app could give IBD patients a practical tool to manage their diet and potentially reduce flare-ups and symptoms, though more research is needed to confirm benefits
The Research Details
This is a pilot randomized controlled trial, which means researchers randomly assigned 40 IBD patients into two groups. One group used the MyIBDDiet app for the full 60 days, while the other group received their usual medical care for the first 30 days, then switched to using the app for the remaining 30 days. This crossover design lets researchers see how the app affects each person.
The MyIBDDiet app was created by working directly with IBD patients to understand what they needed. The app helps people track what they eat and provides personalized guidance about which foods might help reduce inflammation and improve their symptoms. Researchers measured success using multiple methods: they asked users about the app’s ease of use through questionnaires and interviews, tracked changes in diet quality using food surveys, measured inflammation markers in blood and stool samples, and assessed how the app affected quality of life and IBD symptoms.
This pilot study is smaller and shorter than a full research trial. Its main purpose is to test whether the app works well enough and is easy enough to use to justify a larger, more expensive study in the future.
This research approach is important because most health apps haven’t been properly tested to see if they actually work. By involving IBD patients in designing the app from the start, researchers made sure it addresses real patient needs. Testing both usability (is it easy to use?) and effectiveness (does it improve health?) gives a complete picture of whether the app is worth using and developing further.
This study has several strengths: it’s randomized (reducing bias), it includes both quantitative measurements (blood tests, diet surveys) and qualitative feedback (interviews), and it was registered before starting (ClinicalTrials.gov #NCT06683105). However, as a pilot study with only 40 participants at one center, results may not apply to all IBD patients. The 60-day timeframe is relatively short for seeing major health changes. Final results haven’t been published yet, so we’re looking at the planned study design rather than actual findings.
What the Results Show
This is a protocol paper describing the planned study design rather than actual results. The researchers have not yet completed the trial or published their findings. The primary goal is to measure how usable and acceptable the MyIBDDiet app is for IBD patients using standardized questionnaires and patient interviews. They will assess whether the app is intuitive, whether patients find it helpful, and whether they would continue using it.
The study will also examine whether using the app leads to measurable improvements in diet quality. Researchers will use multiple diet assessment tools to track whether patients eat more anti-inflammatory foods and fewer processed foods that might trigger symptoms. They’ll measure salt intake through urine tests and track overall diet quality using established scoring systems.
Secondary measurements will include blood and stool tests to check for signs of inflammation (C-reactive protein and fecal calprotectin), patient-reported symptoms and quality of life scores, and safety monitoring. The exploratory outcomes include analyzing changes in gut bacteria and metabolites, which are chemical compounds produced by the body.
Beyond usability and diet quality, researchers will track clinical outcomes important to IBD patients: disease activity (how severe symptoms are), inflammation markers, and quality of life. They’ll also collect data from the app itself—how often people use it, which features they access most, and how their usage patterns change over time. This digital analytics data helps researchers understand which app features are most valuable to users.
Recent medical guidelines increasingly recognize that diet plays an important role in managing IBD, yet few apps have been scientifically tested for effectiveness. Most existing health apps for IBD focus on symptom tracking rather than dietary guidance and self-management. MyIBDDiet is notable because it was co-designed with IBD patients and includes comprehensive evaluation of both usability and clinical outcomes. This study fills a gap by formally testing whether a diet-focused app can improve health outcomes in IBD patients.
As a pilot study, this research has important limitations. With only 40 participants at one medical center, results may not apply to all IBD patients or different populations. The 60-day study period is relatively short—meaningful changes in inflammation and gut health may take longer. The study doesn’t yet have published results, so we cannot assess actual effectiveness. Additionally, people who volunteer for app studies may be more tech-savvy or motivated than typical IBD patients, which could affect how well the app works in real-world use.
The Bottom Line
This is a pilot study, so strong recommendations aren’t yet possible. However, if you have IBD and are interested in dietary management, this research suggests that a well-designed, patient-centered app could be a useful tool. Talk with your gastroenterologist about dietary approaches for your specific type of IBD. If the full trial results are positive, MyIBDDiet may become a recommended resource. For now, focus on established IBD dietary guidelines and work with a registered dietitian familiar with IBD.
This research is most relevant to people with inflammatory bowel disease (Crohn’s disease or ulcerative colitis) who want to manage their condition through diet. It’s also important for healthcare providers, app developers, and researchers working on digital health tools for chronic disease management. People without IBD won’t benefit from this specific app, though the research approach could inform apps for other digestive conditions.
This is a pilot study, so results won’t be available immediately. The 60-day trial period suggests researchers expect some measurable changes in diet quality and possibly inflammation markers within 2 months. However, more substantial improvements in IBD symptoms and quality of life typically take longer. If this pilot is successful, a larger trial would follow, potentially taking 1-2 years to complete and publish.
Frequently Asked Questions
Can a diet app really help with inflammatory bowel disease symptoms?
Diet plays an increasingly recognized role in IBD management, and this pilot study will test whether a specialized app helps patients eat better and reduce inflammation. Results aren’t available yet, but the research approach is scientifically sound and addresses a real gap in IBD care tools.
How does the MyIBDDiet app work differently from other food tracking apps?
MyIBDDiet was specifically designed for IBD patients by working directly with them to understand their needs. Unlike generic food trackers, it provides anti-inflammatory dietary guidance tailored to IBD and tracks disease-specific outcomes like inflammation markers and symptom changes.
When will the MyIBDDiet app be available to use?
This pilot study is currently underway and hasn’t published results yet. If successful, a larger trial would follow before the app becomes widely available. Talk with your gastroenterologist about current availability or similar dietary management tools.
What should I do about my IBD diet while waiting for these research results?
Work with your gastroenterologist and a registered dietitian familiar with IBD to identify your personal food triggers and follow established IBD dietary guidelines. Keep a food and symptom diary to track patterns, and discuss dietary modifications that help your specific condition.
Is this study only for people with Crohn’s disease or does it include ulcerative colitis too?
The MyIBDDiet app is designed for all people with inflammatory bowel disease, including both Crohn’s disease and ulcerative colitis. The pilot study includes both conditions, though results may vary based on individual disease characteristics and severity.
Want to Apply This Research?
- Track daily food intake and IBD symptoms (pain, bowel movements, energy level) using a simple 1-10 scale to identify which foods trigger your symptoms and which help you feel better
- Start by logging one meal per day in the app, gradually increasing to all meals as the habit becomes routine; use the app’s anti-inflammatory food suggestions to swap one processed food item daily with a healthier alternative
- Review your food and symptom logs weekly to identify patterns; share monthly summaries with your healthcare provider to adjust your diet plan; track inflammation markers (if available) every 3 months through blood tests
This article describes a pilot research study that is currently underway; final results have not yet been published. The MyIBDDiet app is being tested in a research setting and is not yet approved as a medical treatment. If you have inflammatory bowel disease, consult your gastroenterologist before making significant dietary changes. This research is not a substitute for professional medical advice, diagnosis, or treatment. Do not use this information to self-diagnose or self-treat IBD. Always work with your healthcare provider and a registered dietitian to develop a personalized dietary plan appropriate for your specific condition.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.